Mycobacterium bovis BCG: the importance of an accurate identification in the diagnostic routine
AbstractM. bovis BCG is used clinically in the immunotherapy treatment of superficial bladder cancer to prevent progression to invasive disease, leading in some cases to a severe localized inflammation or disseminated infections. For this reason, an accurate and early identification of this particular microorganism is clinically relevant.We describe a case-report of bladder cancer with a urine culture-positive for mycobacteria initially diagnosed as MTB complex infection and later identified as BCG disease by molecular methods.
- Abstract views: 680
- PDF: 912
Copyright (c) 2010 Antonella Grottola, Anna Fabio, Anna MT Sabbatini, Giuliana Fabio,, Mariagrazia Apice, Alessia Di Nauta, Giulia Forbicini, Annunziata La Regina, Sara Tagliazucchi, Monica Pecorari, Fabio Rumpianesi, Chiara Casolari
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.